Company: IMRX
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0001790340-25-000042
Chunk: 75

Company: Immuneering Corp
Filing Date: 2025-03-20
Form: 10-K
Item: Item 15
Chunk 75
---
uneering Corporation10-K001-4067510.403/01/202410.5†Letter Agreement, by and between Immuneering Corporation and Mallory Morales, dated as of July 25, 20228-K001-4067510.107/25/202210.6†Letter Agreement, dated June 14, 2023, by and between Mallory Morales and Immuneering Corporation10-K001-4067510.603/01/202410.7†Separation Agreement and Release, by and between Scott Barrett and Immuneering Corporation, dated November 8, 202310-Q001-4067510.211/09/202310.8†Employment Agreement, dated March 24, 2023, by and between Harold E. Brakewood and Immuneering Corporation10-K001-4067510.803/01/202410.9†Employment Agreement, Dated July 23, 2021, by and between Michael Bookman and Immuneering CorporationS-1/A333-25779110.907/26/202110.10†Immuneering Corporation 2008 Stock Incentive Plan and form of option agreement thereunder.S-1333-25779110.407/09/202110.11†Immuneering Corporation Long Term Incentive Plan and form of option agreement thereunderS-1333-25779110.507/09/202110.12†Immuneering Corporation 2021 Incentive Award Plan and forms of award agreements thereunderS-1/A333-25779110.1007/26/202110.13†Immuneering Corporation 2021 Employee Stock Purchase Plan.S-1/A333-25779110.1107/26/202110.14†Immuneering Corporation 2025 Employment Inducement Award Plan and forms of award agreements thereunder*10.15Equity Distribution Agreement, dated as of August 10, 2022, by and between Immuneering Corporation and Piper Sandler & Co.S-3333-2667381.28/10/202210.16†Form of Indemnification Agreement by and among the Registrant and its directors and officers.S-1/A333-25779110.1207/26/202110.17†Immuneering Corporation Non-Employee Director Compensation Program, as amended, effective May 21, 202410-Q001-4067510.108/